This Week in HIV Research: Where Are the Cervical Cancer Screens?

This Week in HIV Research: Where Are the Cervical Cancer Screens?

1 of 5
Next >

Headlining our latest glimpse at recently published HIV research are a couple of studies that highlight the frustrating gap that so often seems to exist between reality and best practices or intentions. This week, we see:

  • Poor rates of cervical cancer screening among HIV-positive women of color.
  • A lot of interest, but little action, when it comes to organ donation among people with HIV.
  • Encouraging signs for an online depression intervention aimed at people with HIV.
  • No significant differences by sex in hair-derived drug concentrations of tenofovir disoproxil fumarate/emtricitabine (Truvada).

Learn more about the specific findings of each of these studies in the coming paragraphs. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: designer491 via iStockphoto

Headlining our latest glimpse at recently published HIV research are a couple of studies that highlight the frustrating gap that so often seems to exist between reality and best practices or intentions. This week, we see:

  • Poor rates of cervical cancer screening among HIV-positive women of color.
  • A lot of interest, but little action, when it comes to organ donation among people with HIV.
  • Encouraging signs for an online depression intervention aimed at people with HIV.
  • No significant differences by sex in hair-derived drug concentrations of tenofovir disoproxil fumarate/emtricitabine (Truvada).

Learn more about the specific findings of each of these studies in the coming paragraphs. To beat HIV, you have to follow the science!

Barbara Jungwirth is a freelance writer and translator based in New York. Follow Barbara on Twitter: @reliabletran.

Myles Helfand is the executive editor and general manager of TheBody.com and TheBodyPRO.com. Follow Myles on Twitter: @MylesatTheBody.

Image Credit: designer491 via iStockphoto